Navigation Links
Phase 3 Data Show Intravenous Golimumab Inhibited Radiographic Progression in Patients with Active Rheumatoid Arthritis
Date:11/12/2012

he product in the United States.  Janssen pharmaceutical companies market SIMPONI in Canada, Central and South America, the Middle East, Africa and Asia Pacific. 

In Japan, Indonesia and Taiwan, Janssen Biotech, Inc. licenses distribution rights to SIMPONI to Mitsubishi Tanabe Pharma Corporation and has retained co-marketing rights in those countries.  In Europe, Russia and Turkey, Janssen Biotech, Inc. licenses distribution rights to SIMPONI to Schering-Plough (Ireland) Company, a subsidiary of Merck & Co., Inc. 

The U.S. full prescribing information for SIMPONI can be accessed at the following link:  http://www.simponi.com/sites/default/files/pdf/prescribing-information.pdf.

For further information about SIMPONI outside of the United States, please consult the relevant official product information applicable to that country location

Important Safety Information About SIMPONI Subcutaneous Formulation
SIMPONI® (golimumab) is a prescription medicine. SIMPONI® can lower your ability to fight infections. There are reports of serious infections caused by bacteria, fungi, or viruses that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these infections have been fatal. Your doctor will test you for TB before starting SIMPONI® and will monitor you for signs of TB during treatment. Tell your doctor if you have been in close contact with people with TB. Tell your doctor if you have been in a region (such as the Ohio and Mississippi River Valleys and the Southwest) where certain fungal infections like histoplasmosis or coccidioidomycosis are common. 

You should not start SIMPONI® if you have any kind of infection. Tell your doctor if you are prone to or have a history of infections or have di
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
2. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
3. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
6. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
7. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
8. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
9. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
10. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
11. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014  Columbia Laboratories, Inc. ... a provider of pharmaceutical development, clinical trial manufacturing, and ... today announced that it will participate at the upcoming ... Conference, to be held in New York ... at 11:15am on September 9, 2014 at the New ...
(Date:8/27/2014)... NORWALK, Conn. , Aug. 27, 2014  UBM ... , a leading online community for medical imaging professionals, ... Association for Medical Imaging Management,s 2014 Annual Meeting ... the conference coverage: , 11 Principles ... management can lead to greater profitability. , ...
(Date:8/27/2014)... , Aug. 27, 2014 Ambit Biosciences (Nasdaq: ... development of drugs targeting unmet needs in oncology, autoimmune and ... 2014 Health Care Conference to be held at The New ... on September 3-4, 2014. Alan Fuhrman ... and its lead drug candidate, quizartinib, at 1:10 p.m. ET ...
Breaking Medicine Technology:Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3Ambit Announces Participation At Baird 2014 Health Care Conference 2
... YORK, May 25, 2011 Reportlinker.com ... report is available in its catalogue: ... Market Outlook in United Kingdom to ... Infusion Systems, Central Venous Catheters and ...
... NEW YORK, May 25, 2011 ... research report is available in its ... Devices Market Outlook in Russian Federation ... Devices, Infusion Systems, Central Venous Catheters ...
Cached Medicine Technology:Reportlinker Adds Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 2Reportlinker Adds Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 3Reportlinker Adds Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 4Reportlinker Adds Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 5Reportlinker Adds Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 6Reportlinker Adds Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 7Reportlinker Adds Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 8Reportlinker Adds Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 9Reportlinker Adds Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 10Reportlinker Adds Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 11Reportlinker Adds Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 12Reportlinker Adds Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 2Reportlinker Adds Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 3Reportlinker Adds Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 4Reportlinker Adds Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 5Reportlinker Adds Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 6Reportlinker Adds Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 7Reportlinker Adds Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 8Reportlinker Adds Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 9Reportlinker Adds Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 10Reportlinker Adds Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 11Reportlinker Adds Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 12
(Date:8/27/2014)... BRIC Laparoscopes Market Outlook to 2020 ... market data on the BRIC Laparoscopes market. The report ... units) and average prices (in US dollars) within market ... Tip Video Laparoscopes), Robotic Surgical Systems and Rigid Tip ... to the patient with laparoscopic surgery versus the more ...
(Date:8/27/2014)... Sound Telecom, a leading telecommunications company that ... communication systems, has unveiled an article titled “ Three ... Messaging .” The piece examines the world of medical ... remain compliant with HIPAA and HITECH requirements. , ... at Sound Telecom, opens with evidence that the use ...
(Date:8/27/2014)... York, New York (PRWEB) August 27, 2014 ... hip lawsuits ( http://www.consumerinjurylawyers.com/DePuy/ ) has extended the deadline ... According to an August 2014 Order issued by U.S. ... Ohio, those wishing to enroll in the DePuy ASR ... (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products ...
(Date:8/27/2014)... York (PRWEB) August 27, 2014 As ... society today, big business has taken notice. With 23 ... of medical cannabis friendly legislation on their books the ... states such as New York and Florida are in ... medical marijuana laws a void of reliable information and ...
(Date:8/27/2014)... WEDNESDAY, Aug. 27, 2014 (HealthDay News) -- There,s been ... antidepressants by women during their pregnancies might raise the ... Now, a study involving more than 13,000 children finds ... children whose mothers used an antidepressant while pregnant, but ... (ADHD) in these youngsters. The findings challenge prior ...
Breaking Medicine News(10 mins):Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 2Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 3Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 4Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 2Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 3Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 3Health News:The Marijuana Real Estate Market Opens Up 2Health News:The Marijuana Real Estate Market Opens Up 3Health News:Do Antidepressants in Pregnancy Raise Risks for Mental Woes in Kids? 2Health News:Do Antidepressants in Pregnancy Raise Risks for Mental Woes in Kids? 3
... of bacteria found in soil boosts happiness levels and could ... and prone to infection, says a study. ,British ... cancer patients with the bacteria, named 'bacterium Mycobacterium vaccae', and ... edition of BBC News. ,However, they said ...
... our stomach may reduce the protective effects of antioxidants ... Glasgow found that in the presence of lipid the ... component of vitamin C), to protect against the generation ... than when no lipids are present. “Our results illustrate ...
... doctors attempting to conduct tests on Mt Everest,// the highest peak ... Nepal government said the research was illegal. ,The ... University College London had announced in 2005 that it would lead ... the amount of oxygen in their own blood on the summit ...
... reports of stray dogs in metropolitan cities killing small children ... out protests from hundreds of animal lovers. // ,Recently ... stray dogs in Hyderabad. Authorities had caught about 22,000 ... Bangalore has led to an uproar with animal rights activists ...
... you are looking for the perfect partner in life, forget ... // ,Researchers at Manchester University in northern Britain said ... concluded that the zodiac had no impact on chances of ... were released Monday. ,The investigation used census data ...
... celebrate the silver jubilee of The Art of Living in ... free' America initiative;// is being launched by Indian spiritual guru ... to be attended by over 2,500 people along with 20 ... to foster human values such as compassion, friendliness, a sense ...
Cached Medicine News:Health News:Animal Lovers Protest Brutal Dog Killings 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: